Diametric Capital, LP Apellis Pharmaceuticals, Inc. Transaction History

Diametric Capital, LP

  • $173 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$37.14 - $64.82 $368,168 - $642,560
9,913 New
9,913 $593,000
Q2 2023

Aug 11, 2023
BUY
$76.68 - $93.31 $259,178 - $315,387
3,380 New
3,380 $307,000
Q3 2022

Nov 14, 2022
BUY
$44.76 - $69.66 $1.28 Million - $1.99 Million
28,586 New
28,586 $1.95 Million

Others Institutions Holding APLS

# of Institutions
302
Shares Held
112M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.19B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email